NRAVEL
Live / Registered — Registered (as of 05 Dec 2023)
What this means for you
Registered since 05 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79340988
- Registration number
- 7232511
- Mark type
- Stylized text
- Filed
- 23 Aug 2021
- Published for opposition
- 19 Sept 2023
- Registered
- 05 Dec 2023
- Attorney of record
- R. Glenn Schroeder
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals, for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample materials, for medical purposes, namely, tumor tissues and tissue grafts samples, blood, serum, plasma, urine, stools, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites being bodily fluids, cerebrospinal fluid, human and animal urine and human and animal stool; test kits of human and animal sample materials, comprising diagnostic reagents for medical purposes, namely, human and animal allograft and xenograft tissue, tissue cuts being biological tissue grafts and biological tissue cultures, blood plasma, blood serum, ascites being bodily fluids, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for medical use; therapeutic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods, for medical use for the treatment of cancer; biological material collections, namely, biological tissue cultures for medical purposes; cancer material collections, namely, biological tissue being resected and biopsy tumor and adjacent non-tumor tissue from the human body including epithelial, connective, muscular, and nervous tissues, blood, serum, plasma, urine, stools for medical purposes; medical sample collections, namely, biological tissue cultures for medical purposes; biological sample collections from the human body, namely, epithelial, connective, muscular, and nervous tissues, blood, serum, plasma, urine, stools for medical purposes; biopsy material collections, namely, biological tissue in the nature of blood, biological tissue grafts and biological tissue cultures for medical purposes; all the afore-mentioned in particular with regard to the field of oncology
- Class 042 — Scientific and technological services: Collection of clinical data for medical research and development of therapeutics and diagnostics; collecting genetic, medical, biomedical, biologic, chemical and biochemical data and information, in particular information generated through the use of imaging techniques, the use of liquid biopsy methods, the use of histopathological analysis and procedures, the use of genetic analysis and the use of genomics, proteomics, transcriptomics, metabolomics, lipidomics and/or glycomics studies and analysis for medical research; scientific and technological services, namely, research, design and development of new technology for others in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; industrial analysis and research services in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, namely, molecular biological, immunological and histological laboratory services, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy; typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods for research purposes; preparation of human and animal biospecimen for research purposes; providing information and data relating to medical and veterinary research on human and animal biospecimen, in particular genomic, epigenomic, proteomic, phosphoproteomic, RNA, transcriptomic, lipidomic and metabolomic data; medical laboratory services for medical research purposes, other than for diagnostic or treatment purposes, namely, typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods; database design and development; software as a service (SAAS) services, namely, hosting software for use by others for use as a database; installation, maintenance and updating of database software; providing scientific research information and results from an online searchable database; programming of computer software for databases; scientific and laboratory analysis using bioinformatics and computational biology in the field of oncology; all the afore-mentioned in particular with regard to the field of oncology
- Class 044 — Medical, beauty and agricultural services: Medical analyses in connection with the treatment of individuals including medical analysis of X-rays and blood samples, namely, medical testing for diagnostic and treatment purposes; medical clinic services; pharmaceutical advisory services; medical analysis services using bioinformatics and computational biology, for patient diagnostic and treatment purposes; providing supporting services and advice to hospitals and other medical care centres, namely, collecting and stabilizing of human and animal biospecimens, providing advice related thereto, and the collection of related clinical data for patient diagnostic and treatment purposes; all the afore-mentioned in particular with regard to the field of oncology
Owner
- Indivumed GmbH, DE
- Indivumed GmbH, DE
- Indivumed GmbH, DE
- Indivumed GmbH, DE
Prosecution history
- 14 May 2024 — USPTO CORRECTION PROCESSED BY IB
- 23 Apr 2024 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 08 Apr 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 14 Mar 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 14 Mar 2024 — FINAL DISPOSITION PROCESSED
- 14 Mar 2024 — CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
- 13 Mar 2024 — CORRECTION UNDER SECTION 7 - PROCESSED
- 05 Mar 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 30 Oct 2023 — USPTO CORRECTION PROCESSED BY IB
- 30 Oct 2023 — CORRECTION TRANSACTION RECEIVED FROM IB
- 25 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 25 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB